MicroVision, Inc. Files Material Definitive Agreement 8-K
Ticker: MVIS · Form: 8-K · Filed: 2025-02-03T00:00:00.000Z
Sentiment: neutral
Topics: material-definitive-agreement, 8-k
TL;DR
MicroVision just signed a big deal, filing an 8-K on it.
AI Summary
On February 3, 2025, MicroVision, Inc. filed an 8-K report detailing a material definitive agreement. The filing does not provide specific details on the agreement's nature or any associated dollar amounts, but it indicates a significant event for the company.
Why It Matters
This filing signals a significant new contract or partnership for MicroVision, Inc., which could impact its future revenue and strategic direction.
Risk Assessment
Risk Level: medium — The filing indicates a material definitive agreement, which is significant, but lacks specific details, creating uncertainty about its immediate impact.
Key Players & Entities
- MicroVision, Inc. (company) — Registrant
- February 3, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- Redmond, Washington (location) — Principal executive offices
FAQ
What is the nature of the material definitive agreement filed by MicroVision, Inc.?
The filing does not specify the nature of the material definitive agreement.
When was the material definitive agreement entered into or reported?
The report date for the material definitive agreement was February 3, 2025.
What is MicroVision, Inc.'s principal executive office address?
MicroVision, Inc.'s principal executive offices are located at 18390 NE 68th Street, Redmond, Washington 98052.
What is MicroVision, Inc.'s telephone number?
MicroVision, Inc.'s telephone number is (425) 936-6847.
What is the SEC file number for MicroVision, Inc.?
MicroVision, Inc.'s SEC file number is 001-34170.
Filing Stats: 1,312 words · 5 min read · ~4 pages · Grade level 11.8 · Accepted 2025-02-03 09:14:38
Key Financial Figures
- $0.001 — ange on which registered Common Stock $0.001 Par Value MVIS The Nasdaq Stock Mar
- $45 million — incipal amount for the initial note was $45 million . On February 3, 2025, the Company ente
- $11,550,000 — ments for the total aggregate amount of $11,550,000 with respect to Partial Redemption Date
- $2,750,000 — ore, the Investor has agreed to convert $2,750,000 of the currently outstanding Initial Pr
- $5,975,000 — onable efforts to convert the remaining $5,975,000 of the currently outstanding Initial Pr
- $8 million — gregate purchase price of approximately $8 million. The sale of the Securities pursuant to
- $1.57 — mon Stock at an exercise price equal to $1.57 per share. The Warrants will be exercis
Filing Documents
- form8-k.htm (8-K) — 49KB
- ex4-1.htm (EX-4.1) — 122KB
- ex5-1.htm (EX-5.1) — 11KB
- ex10-1.htm (EX-10.1) — 50KB
- ex10-2.htm (EX-10.2) — 243KB
- ex5-1_001.jpg (GRAPHIC) — 7KB
- 0001493152-25-004615.txt ( ) — 746KB
- mvis-20250203.xsd (EX-101.SCH) — 3KB
- mvis-20250203_lab.xml (EX-101.LAB) — 33KB
- mvis-20250203_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MicroVision, Inc. Date: February 3, 2025 By: /s/ Drew G. Markham Drew G. Markham Senior Vice President, General Counsel and Secretary